Curis | CRIS - Interest Expense On Debt


Curis reported $178K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Amgen USD 95.64B 94.98B Jun/2026
AstraZeneca USD 340M 144M Jun/2026
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Gilead Sciences USD 247M 7M Jun/2026
GlaxoSmithKline GBP 121M 46M Jun/2026
Incyte USD 582K 13K Jun/2026
Merck USD 525M 46M Jun/2026
Novartis USD 462M 119M Jun/2026
Pfizer USD 667M 4M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 287M 109M Jun/2026
Takeda JPY 63.85B 20.2B Jun/2026
TG Therapeutics USD 16.57M 8.91M Jun/2026
Verastem USD 382K 33K Mar/2026